Kalıcı Tünelli Hemodiyaliz Kateter Disfonksiyonu ile İlişkili Risk Faktörleri; Tek Merkez Deneyimi

Amaç: Kronik böbrek yetmezliği (KBY) olan hastalarda hemodiyaliz için kalıcı tünelli kaflı kateterler sık tercih edilmektedir, ancak bu kateterlerin disfonksiyonu ile ilişkili risk faktörleri yeterince bilinmemektedir. Amacımız bu risk faktörlerini araştırmak. Gereç ve Yöntem: Çalışmaya, KBY tanısı ile 2014-2019 yılları arasında hastanemiz Radyoloji kliniğinde, santral vene ilk defa kalıcı tünelli kateter yerleştirilmiş ve izlemde kateter disfonksiyonu gelişmiş tüm hastalar dahil edildi. Hastaların demografik ve klinik verileri dosya kayıtlarından elde edildi. Kateter disfonksiyon nedenleri ile diyabet ve hipertansiyon varlığı arasındaki ilişki karşılaştırıldı. Bulgular: Toplam 123 hastanın 63’ü (%63,4) erkek ve medyan yaş 55 (28-78) yıl saptandı. Hastaların 29’unda (%23,6) tromboz, 72’sinde (%58,5) venöz stenoz ve 22’sinde (%17,9) fibrin kılıfına bağlı kateter disfonksiyonu gelişti. Disfonksiyon grupları birbiriyle yaş, cinsiyet, kateterin çalışma süresi, KBY etiyolojisi, komorbid hastalıklar, kateterin yerleştirildiği ven ve antikoagülan kullanımı açısından karşılaştırıldı. Tromboz erken döenemde gelişen disfonksiyonun en önemli nedeni idi. Hipertansiyonu olan hastalarda en önemli disfonksiyon nedeninin venöz stenoz, KBY etiyolojisinde diyabeti olanlarda ve KBY’ne eşlik eden diyabeti olanlarda ise en önemli tromboz nedeninin tromboz olduğu görüldü (p

Risk Factors Associated with Dysfunction of Permanent Tunneled Cuffed Hemodialysis Catheters; Single Center Experience

Purpose: Permanent tunneled cuffed catheters are frequently preferred for hemodialysis in patients with chronic renal failure (CRF), but the factors associated with the dysfunction of these catheters are not well known. Our goal is to investigate these risk factors. Materials and Methods: All cases with a diagnosis of CRF and a permanent tunneled cuffed catheter inserted into the central vein for the first time in our radiology clinic between 2014 and 2019 and who developed catheter dysfunction were included in the study. Demographic and clinical data of the cases were obtained from file records. The relationship between the causes of catheter dysfunction and the presence of diabetes and hypertension was investigated. Results: Of the total 123 cases, 78 (63.4%) were male, 45 (36.6%) were female, the median age was 55 (28-78). Twenty-nine (23.6%) of the cases had thrombosis, 72 (58.5%) had venous stenosis and 22 (17.9%) had catheter dysfunction due to fibrin sheath. Dysfunction groups were compared with each other in terms of age, gender, duration of operation of the catheter, CRF etiology, comorbid diseases, the vein where the catheter was placed and the use of anticoagulants. The most important cause of catheter dysfunction in the early period was thrombosis (p = 0.003). When the causes of dysfunction were examined, the most common causes of dysfunction were venous stenosis in patients with hypertension, thrombosis in patients with diabetes as a concomitant disease without diabetes in the etiology of CRF, and thrombosis in patients with diabetes in CRF etiology (p

PDF

___

1. Peter R and Bream PR Jr. Update on insertion and complications of central venous catheters for hemodialysis. Semin Intervent Radiol. 2016;33:31-8. DOI:10.1055/s-0036-1572547
2. Quarello F, Forneris G, Borca M, et al. Do central venous catheters have advantages over arteriovenous fistulas or grafts? J Nephrol. 2006;19:265-79.
3. Labriola L and Pochet JM. Any use for alternative lock solutions in the prevention of catheter-related blood stream infections? J Vasc Access. 2017;18:S34-8. DOI: 10.5301/jva.5000681
4. Ibeas-Lopez, J. New technology: Heparin and antimicrobial-coated catheters. J Vasc Access. 2015;S16:48-53. DOI:10.5301/jva.5000376
5. Lok C, Huber T, Lee T, et al. KDOQI Clinical Practice Guidelines for Vascular Access: 2019 Update. Am J Kidney Dis. 2020;75:S1-164. DOI:10.1053/j.ajkd.2019.12.001
6. Timsit JF. What is the best site for central venous catheter insertion in critically ill patients? Crit Care. 2003;7:397-9. DOI:10.1186/cc2179
7. Kelber J, Delmez JA and Windus DW. Factors affecting delivery of high-efficiency dialysis using temporary vascular access. Am J Kidney Dis. 1993;22:24-9. DOI:10.1016/s0272-6386(12)70162-2
8. Rathi M, Pinnamaneni VST and Sakhuja V. Non-imaging assisted insertion of un-cuffed, non-tunneled internal jugular venous catheters for hemodialysis: Safety and utility in modern day world. Biomed J. 2016;39:283-8. DOI:10.1016/j.bj.2015.12.004
9. Maya ID and Allon M. Outcomes of tunneled femoral hemodialysis catheters: Comparison with internal jugular vein catheters. Kidney Int. 2015;68:2886-9. DOI: 10.1111/j.1523-1755.2005.00762.x
10. Engstrom BI, Horvath JJ, Stewart JK, et al. Tunneled internal jugular hemodialysis catheters: Impact of laterality and tip position on catheter dysfunction and infection rates. J Vasc Interv Radiol. 2013;24:1295-1302. DOI:10.1016/j.jvir.2013.05.035
11. Shingarev R, Barker-Finkel J and Allon M. Natural history of tunneled dialysis catheters placed for hemodialysis initiation. J Vasc Interv Radiol. 2013;24:1289-94. DOI:10.1016/j.jvir.2013.05.034
12. Shi M, Cui T, Ma L, et al. Catheter failure and mortality in hemodialysis patients with tunneled cuffed venous catheters in a single center. Blood Purif. 2017;43:321-6. DOI: 10.1159/000455062
13. Coentrao L, Santos-Araujo C, Dias C, et al. Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: A retrospective cohort study. BMC Nephrol. 2012;13:88. DOI: 10.1186/1471-2369-13-88
14. Ponce D, Mendes M, Silva T, et.al. Occluded tunneled venous catheter in hemodialysis patients: Risk factors and efficacy of alteplase. Artif Organs. 2015;39:741-7. DOI:10.1111/aor.12462
15. Wang K, Wang P, Liang X, et.al. Epidemiology of haemodialysis catheter complications: A survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China. BMJ Open. 2015;5:e007136. DOI:10.1136/bmjopen-2014-007136
16. Szarnecka-Sojda A, Jacheć W, Polewczyk M, et.al. Risk of complications and survival of patients dialyzed with permanent catheters. Medicina (Kaunas). 2019;56:2. DOI:10.3390/ medicina56010002
17. Fox J, Joubert G and Loggenberg E. Tunnelled haemodialysis catheters in central free state: Epidemiology and complications. SA J Radiol. 2019;23:1791. DOI:10.4102/sajr.v23i1.1791
18. Valliant AM, Chaudhry MK, Yevzlin AS, et.al: Tunneled dialysis catheter exchange with fibrin sheath disruption is not associated with increased rate of bacteremia. J Vasc Access. 2015;16:52-6. DOI:10.5301/jva.5000301
19. Vats HS. Complications of catheters: Tunneled and non-tunneled. Adv Chronic Kidney Dis. 2012;19:188-94. DOI: 10.1053/j. ackd.2012.04.004
20. Campean V, Neureiter D, Varga I, et al. Atherosclerosis and vascular calcification in chronic renal failure. Kidney Blood Press Res. 2005;28:280-9. DOI:10.1159/000090182
21. Afzal A, Ulhaq AU, Ahmed A, et al. Hemodialysis patients; Central vein stenosis following temporary double lumen catheterization in internal jugular and subclavian veins. The Prof Med J. 2017;24:8
22. Schon D and Whittman D. Managing the complications of longterm tunneled dialysis catheters. Semin Dial. 2003;16:314–22. DOI: 10.1046/j.1525-139x.2003.16060.x
23. Rackoff WR, Weiman M, Jakobowski D, et al. A randomised, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr. 1995;127:147-51. DOI:10.1016/s0022-3476(95)70276-8
24. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central vein catheters. Ann Intern Med. 1990;112:423-8. DOI:10.7326/0003-4819-76-3-112-6-423